SEARCH · Search PubMed

Results for “Ethnobotany”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

SourceResearch connectionFrom yearThrough year

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources

PubMed1994

Basic, quantitative and experimental research phases of future ethnobotany with reference to the medicinal plants of South America.

Ethnobotany of the future will encompass what we perceive as three interrelated research phases. Basic ethnobotany includes the compilation and organization of information about biota obtained from indigenous and other peoples, such as obtaining data about useful plants and animals, understanding how peoples manage their environments and learning about their lexicons and classifications. This is what we try to do in the best possible way, directly in the field from original sources. These results can then be organized in many ways once species determinations are completed. They may also be organized using other types of information, the most obvious being chemical, medical and linguistic. Quantitative ethnobotany develops methods to allow quantitative description and to evaluate and analyse primary data sets. Original field research must be sufficiently structured and consistent, for example in relation to forest habitat and composition or to oral exchanges between informant and listener, so that statistical techniques may be used to test proposed hypotheses rigorously. This aspect of ethnobotany is in its infancy, yet it can be broadly utilized to comprehend more meaningfully and usefully ethnobotanically valued plants, particularly in the exceedingly diversified environments of tropical regions where because of community isolation practitioners are still most knowledgeable. Experimental ethnobotany involves the use of biota in search of products for industrial, medical and other purposes. Plant ethnomedicinal findings may set the stage for targeting materials which can be meaningfully analysed for chemical activity using appropriate biodirected assays. This approach in search of new pharmaceuticals is woefully underutilized today to the detriment of human health and a number of new strategies should be considered for future advancements in drug discovery. These aspects of ethnobotany will be evaluated largely in relation to current and future research in South America.

Forecasting↗

PubMedDate not supplied

The world's longest surviving paediatric practices: some themes of Aboriginal medical ethnobotany in Australia.

Contemporary paediatric practices of Australian Aboriginal men and women, in more than 100 Aboriginal Language Groups, comprise a living discipline whose origins predate Western medicine by tens of millennia. The history of paediatrics acknowledges this surviving continuum of the world's oldest child-care practices. Because of the inextricable nexus between Aboriginal men and women and the land in which they live, medical ethnobotany forms a major part of the medical aspects of Aboriginal child care. Traditional tribal healers, called 'Nungungi' in some language groups of Central Australia, are identified as such whilst still young children and are given special education in the healing arts, especially that of medical ethnobotany, by older healers. Distinct from this specialized role, all Aboriginal men and women (and in particular grandmothers) in traditional communities use a sophisticated botanical materia medica in the treatment of sick and injured children. In cultures in transition, medical ethnobotanical practices may persist long after the local use of flora as sources of traditional food, weaponry, totemic identity and religious rites have disappeared. Some selected botanical 'cures' were adopted by early European settlers and a number of such relict uses have become part of mainstream Western life today, particularly as this applies to self-medication. Drugs and medicaments used in the treatment of children are obtained from leaves, bark, roots and flowers, usually as fresh preparations. They are prepared as infusions, decoctions and macerations and may be enjoined with emollients such as emu or kangaroo fat for topical application. Botanical drugs and medicaments are usually prepared fresh for each administration and are rarely stored. Contemporary Australian ethnobotany exploits the medicinal properties of more than 100 genera - using such extracts as antiseptics, analgesics, astringents, antipyretics, sedatives, hypnotics, expectorants and carminatives. Their widespread use, by the world's oldest surviving cultures, reflect perhaps 50 millennia of acute observation and clinical interpretation, trial and error, serendipidity and experimentation. Australian medical ethnobotany generally, and that used specifically for children, is characterized by several features including (i) the multipurpose or 'broad-spectrum' use of many floral species; (ii) a paradigm of the use of botanical material to treat symptoms and symptom-complexes rather than disease-based treatment; (iii) the widespread and universal medical knowledge of botanical remedies by all members of local Aboriginal communities, not only traditional community or tribal healers and (iv) the use of botanical material in the context of preventive medicine. Seventy per cent of the world's population uses traditional herbal remedies in the treatment of sick or injured children. In this context, the detailed and extensive ethnobotanical pharmacopoeia of the Aboriginal Peoples of Australia holds an important place.

Australia↗

PubMed2000

Ethnobotany and its role in drug development.

The botanical collections of early explorers and the later ethnobotany have played important roles in the development of new drugs for many centuries. In the middle of the last century interest in this approach had declined dramatically, but has risen again during its last decade, and new foci have developed. The systematic evaluation of indigenous pharmacopoeias in order to contribute to improved health care in marginalized regions has been placed on the agenda of international and national organizations and of NGOs. In this paper the results of various projects on Mexican Indian ethnobotany and some of the subsequent pharmacological and phytochemical studies are summarized. Medicinal plants are an important element of indigenous medical systems in Mexico. This study uses the medicinal plants in four indigenous groups of Mexican Indians-Maya, Nahua, Zapotec and Mixe-as an example. The relative importance of a medicinal plant within a culture is documented using a quantitative method and the data are compared intra- and interculturally. While the species used by the indigenous groups vary, the data indicate that there exist well-defined criteria specific for each culture, which lead to the selection of a plant as a medicine. For example, a large number of species are used for gastrointestinal illnesses by two or more of the indigenous groups. At least in this case, the multiple transfers of species and their uses within -Mexico seems to be an important reason for the widespread use of a species. Some of the data we gathered in order to evaluate the indigenous claims are also discussed, focusing on the transcription factor NF-kappaB as a molecular target. This led to the identification of sesquiterpene lactones such as parthenolide as potent and relatively specific inhibitors of this transcription factor.

Drugs, Investigational↗

PubMed1994

From shaman to human clinical trials: the role of industry in ethnobotany, conservation and community reciprocity.

Shaman Pharmaceuticals is a development-stage company engaged in developing traditional pharmaceuticals identified through a discovery process focused on isolating active compounds from tropical plants with a history of medicinal use. This process has resulted in two products in clinical trials: Provir, an oral product for the treatment of respiratory viral infections, and Virend, a topical antiviral product for the treatment of herpes. Shaman's drug-discovery process targets specific plants that have been used for medicinal purposes by native peoples. By integrating the sciences of ethnobotany, medicine and plant natural product chemistry, Shaman has been able to achieve time and cost savings for the identification of active compounds and preclinical development of its initial products. Numerous drugs have entered the international pharmacopoeia via the study of ethnobotany and traditional medicine. Two important elements of this approach to drug discovery are the percentage of plants that show activity against specific viral pathogens and the correlation between the folk therapeutic classification of plants used and the percentage of those plants that have shown activity in our antiviral screens. Conservation and direct reciprocity to indigenous communities are important features of Shaman Pharmaceuticals' drug-discovery process.

Clinical Trials as Topic↗

PubMed1994

Ethnobotany, drug development and biodiversity conservation--exploring the linkages.

Numerous ethnobotanical studies aimed at identifying new pharmaceutical products have been initiated in recent times. Ethnobotany has once again become a recognized tool in the search for new pharmaceuticals. Initiatives by governmental agencies and the private sector have helped spark this renewal. Many of these projects are interdisciplinary efforts involving scientists from the fields of anthropology, botany, medicine, pharmacology and chemistry. The Belize Ethnobotany Project links pharmaceutical prospecting with the conservation of traditional medical systems and biological resources. It illustrates the concept of the 'ethno-biomedical reserve' and provides an opportunity for pharmaceutical and herbal industries to contribute to the conservation effort. Terra Nova Rainforest Reserve is an ethno-biomedical reserve in Belize that was given legal status in June of 1993. Too often the exploitation of wild harvested resources has led to their severe degradation. There is a need for increased efforts to develop technologies to sustain their extraction.

Antineoplastic Agents↗

PubMed1984

Tabernaemontana L. (Apocynaceae): a review of its taxonomy, phytochemistry, ethnobotany and pharmacology.

The taxonomy, phytochemistry, ethnobotany, and pharmacology of the genus Tabernaemontana L. (Apocynaceae) is reviewed. The genus is currently being revised taxonomically; most of the segregate genera are being reunited with it and the number of species that will ultimately be recognized will probably be about 100. All the names encountered in the chemical and ethnobotanical literature have been evaluated as far as possible, and a list is presented of the recognized species and their synonyms. The biogenesis and classification of the indole alkaloids found in Tabernaemontana species is set out and some problems in the determination of their stereochemistry are discussed. To facilitate access to the information, three lists have been compiled: the alkaloids in alphabetical order; the alkaloids in order of increasing molecular weight; and the alkaloids grouped according to their biogenetic classification, together with the species and plant part(s) in which they are known to occur. Biogenetic and chemotaxonomic aspects are briefly considered. A table of the non-alkaloidal constituents is also included. The ethnobotany of individual Tabernaemontana species is outlined and an overall assessment made. Likewise, information on the pharmacology of crude extracts and individual alkaloids from Tabernaemontana species has been assembled and appraised.

Alkaloids↗

PubMed1994

Ethnobotany and research on medicinal plants in India.

Vast ethnobotanical knowledge exists in India from ancient time. Since the 1950s the study of ethnobotany has intensified; 10 books and 300 papers have been published. Our work over four decades, both in the field and literary studies, has resulted in a dictionary of Indian folk-medicine and ethnobotany that includes 2532 plants. India has about 45,000 plant species; medicinal properties have been assigned to several thousand. About 2000 figure frequently in the literature; indigenous systems commonly employ 500. Despite early (4500-1500 BC) origins and a long history of usage, in the last two centuries Ayurveda has received little official support and hence less attention from good medical practitioners and researchers. Much work is now being done on the botany, pharmacognosy, chemistry, pharmacology and biotechnology of herbal drugs. The value of ethnomedicine has been realized; work is being done on psychoactive plants, household remedies and plants sold by street drug vendors. Statistical methods are being used to assess the credibility of claims. Some recent work in drug development relates to species of Commiphora (used as a hypolipidaemic agent), Picrorhiza (which is hepatoprotective), Bacopa (used as a brain tonic), Curcuma (antiinflammatory) and Asclepias (cardiotonic). A scrutiny of folk claims found 203 plants for evaluation. Less well known ethnomedicines have been identified that are used to treat intestinal, joint, liver and skin diseases.

India↗

PubMed2006

Quantitative ethnobotany in an atlantic forest fragment of northeastern Brazil: implications to conservation.

An ethnobotanical study was executed in the rural community of the Municipality of "Rio Formoso", starting from the forest inventory accomplished in an Atlantic Forest remnant adjacent to the studied community. Using the methodology of quantitative ethnobotany allied to the ecological parameters (richness, relative frequency, relative density, relative dominance and importance value index) the following results were obtained: 42 inventoried species gathered in 26 families, presented from 1 to 27 means of use for the community. The largest use of the plants is related to obtaining wood in order to be used in house building, firewood production and charcoal. The largest use value was attributed to the Vouacapoua virgilioides (Kunth) Kuntze. The most frequent species were Tapirira guianensis Aubl. (Anacardiaceae), Thyrsodium schomburgkianum Benth. (Anacardiaceae), Schefflera morototoni (Aubl.) Maguire, Steyem. & Frodin (Araliaceae) and Dialium guianense (Aubl.) Sandwith. (Leg-Caesalpinioideae).

Atlantic Ocean↗

PubMed2006

Ethnobotany and ethnopharmacology--interdisciplinary links with the historical sciences.

In this paper we use three disparate examples to highlight the relevance of historical methods in the context of ethnobotany and ethnopharmacology. Unfortunately, in ethnopharmacology we have only very few examples where such historical depth is possible. On the other hand the first hand data available through ethnopharmacological research, may be of relevance for interpreting historical information. Three distinct methods were used successfully in the retrospective exploration of diachronic data. In order to gain an insight into historical developments in the use of plant species and evolution of pharmacopoeias we used a botanico-historical approach (Rosmarinus officinalis), one that combines linguistic and statistical methods (Popoluca/Mixe), and one that uses historical documentary evidence (Ch'orti). We hope that this methodological discussion encourages a wider use of such historical methods in ethnopharmacology and related areas of research.

Ethnobotany↗

PubMed2005

Ethnobotany, phytochemistry and pharmacology of Uncaria (Rubiaceae).

The Uncaria genus is an important source of medicinal natural products, particularly alkaloids and triterpenes. The collected information is an attempt to cover the more recent developments in the ethnobotany, pharmacology and phytochemistry of this genus. During the past 20 years, alkaloids, terpenes, quinovic acid glycosides, flavonoids and coumarins have been isolated from Uncaria. Fifty-three novel structures are reported in this review. The species in which the largest number of compounds has been identified is the Peruvian Uncaria tomentosa or 'cat's claw.' Pharmacological studies are described according to cytotoxicity, anti-inflammatory, antiviral, immunostimulation, antioxidant, CNS-related response, vascular, hypotensive, mutagenicity and antibacterial properties. The potential for development of leads from Uncaria continues to grow, particularly in the area of immunomodulatory, anti-inflammatory and vascular-related conditions. The information summarized here is intended to serve as a reference tool to practitioners in the fields of ethnopharmacology and natural products chemistry.

Adjuvants, Immunologic↗

PubMed1998

Medical ethnobotany of the Zapotecs of the Isthmus-Sierra (Oaxaca, Mexico): documentation and assessment of indigenous uses.

The Zapotec inhabitants of the Sierra de Oaxaca foothills (Mexico) live in an area of great botanic diversity. In daily subsistence and in response to illness, plants play a major role. An inventory of the Zapotec medicinal ethnobotany was carried out during 17 months of fieldwork. A total of 3611 individual responses concerning medicinal and non-medicinal uses for 445 different species of plants were documented. For the subsequent semi-quantitative analysis of data, the uses were grouped into ten categories and the responses for each species were summed up in each of these ten groups to yield rank-ordered lists. For the high rank-ordered and, hence, culturally important species, an assessment of the therapeutic potential was conducted using ethnobotanical, phytochemical and pharmacological data in the literature. Studies confirming the attributed properties or a scientific explanation of therapeutic use, as well as toxicological data, are still lacking for many of these species. The quantitative approach described will be the basis for future studies on the pharmacology and phytochemistry of Zapotec medicinal species. Finally, these data should also serve as a basis for biodiversity conservation and community development.

Ethnobotany↗

PubMed2005

Urinary diseases and ethnobotany among pastoral nomads in the Middle East.

This article is derived from a broad, twenty-year study of ethnobotany and folk medicine among pastoral nomads in the Middle East which took place from 1984 to 2004. The article presents examples of different treatments of diseases and disorders of the urinary tract carried out by healer herbalists. The preparation of remedies includes boiling infusions, extraction of dry or fresh leaves, flowers, seeds or whole plants. Some of these plants were used both as food and as medicine, by ingesting different parts of the plants, such as leaves, flowers, fruits, and so on, either while soft, cooked or dried. Data were collected by using unstructured interviews and by observation. These plants were identified by healers, patients, and university botanists. This paper identified eighty-five plant species, which belong to thirty-six families. The most representative families are: Asteraceae (8), Brassicaceae (6), Poaceae (6), Umbelliferae (6).

Apiaceae↗

PubMed2005

The ethnobotany of Christ's Thorn Jujube (Ziziphus spina-christi) in Israel.

This article surveys the ethnobotany of Ziziphus spina-christi (L.) Desf. in the Middle East from various aspects: historical, religious, philological, literary, linguistic, as well as pharmacological, among Muslims, Jews, and Christians. It is suggested that this is the only tree species considered "holy" by Muslims (all the individuals of the species are sanctified by religion) in addition to its status as "sacred tree " (particular trees which are venerated due to historical or magical events related to them, regardless of their botanical identity) in the Middle East. It has also a special status as "blessed tree" among the Druze.

Adult↗

PubMed2006

Ethnobotany and ethnopharmacy--their role for anti-cancer drug development.

Local and traditional knowledge has been the starting point for many successful drug development projects over the last decades. Here we discuss some examples of anti-cancer drugs which have had enormous impact as anti-cancer agents (camptothecan, taxol and derivatives) and a few examples of drugs currently under various stages of preclinical development. Ethnobotanists investigate the relationship between humans and plants in all its complexity, and such research is generally based on a detailed observation and study of the use a society makes of plants. The requirements of modern research on natural products as, for example, outlined in the Convention on Biological Diversity (Rio Convention) and the overall approach in ethnobotanical research are also discussed. Selected phytochemical-pharmacological studies based on traditional plant use are used to highlight the potential of ethnobotany driven anti-cancer research. The link between traditionally used plants and targets of the NF-kappaB pathway is discussed using on an EU-funded, multidisciplinary project as an example. Lastly the potential of chemopreventive agents derived from traditional food plants is briefly addressed.

Animals↗

PubMed2000

Ethnobotany and the future of conservation.

Ethnobotany is an interdisciplinary science, where botany meets anthropology in the study of traditional uses of native plants. Indigenous peoples know and use a great deal of the plant material around them, though this age-old body of information is now in danger of being lost. How can traditional knowledge and practices help modern conservation and ecology, and how can the possessors of this knowledge retain their rights?

Brazil↗

PubMed1994

Anthropological issues in medical ethnobotany.

While ethnobotany has emerged as an important discipline in the search for new drugs, this economic impetus should in no way distract from a more ethnobiological and equally critical goal--the codification and promotion of indigenous medical systems as a major factor in the conservation of biocultural diversity. Codification of indigenous medical systems requires a holistic view which entails (1) in-depth understanding of the recognized health conditions in the native system and how they might be described in terms of Western biomedicine; (2) comprehensive inventories of medicinal species employed in the native system, descriptions of their modes of preparation and administration and giving priority to those species most likely to merit pharmacological testing; and (3) identification of the pharmacological properties of these species with the goal of discovering how they might be effective in the treatment of the health conditions for which they are employed. Promotion of indigenous medical systems requires the development of local training programmes aimed at the active conservation and enhancement of traditional herbal medicinal therapies that have been shown to be pharmacologically effective in the treatment of symptoms of recognized health conditions. The establishment of such programmes is critical at a time when traditional medical systems are often disparaged as worthless by the national societies in which indigenous peoples live, as well as by younger members of the native populations themselves.

Anthropology↗

PubMed1979

Symbols and selectivity: a statistical analysis of native American medical ethnobotany.

Native Americans use a wide range of plants medicinally. Many of these plants have profound meaning to their users. Does this mean, as some assert, that tribal medicine is "all placebo"? Since the essential character of meaning is the arbitrariness of the sign, then insofar as this medicine is symbolic, the plants used medicinally will be a random representation of plants available in nature. Several regression analyses of plants used by native Americans on plants available to them indicate substantial selectivity in plant use. Native American medical ethnobotany is not only placebo medicine.

Humans↗

PubMed1983

The ethnobotany of chamairo: Mussatia hyacinthina.

Recent fieldwork in the eastern lowlands of Bolivia and Peru has revealed a traditional use of coca (Erythroxylum coca Lam.) as a medicine and stimulant that is distinct from the well-documented customs of the Northwest Amazon and the Andean highlands. In Bolivia some nine indigenous tribes centered mainly in the Rio Beni drainage masticate entire sun-dried coca leaves, yet use as an alkaline additive the crude ash of the spathe or leafbase of the motacú palm (Scheelea princeps (Mart.) Karst.). To the quid they add a piece of the bark of the bignoniaceous liana chamairo (Mussatia sp.), which markedly sweetens the chew. In the montaña of Peru, the liana is also used and a new species is reported from the upper Apurimac river. The ethnobotany of chamairo throughout its range is examined and the need for pharmacological screening is emphasised.

Bolivia↗